Diagnostic antibodies and antigens for Liver Diseases testing: Hyaluronic acid (HA), laminins (LN), collagen type IV (cIV), Procollagen III N-terminal peptide (PIIINP), Lithocholic Acid (LCA), deoxycholic acid (cholanoic acid), hyaluronic acid (HA), Cholyglycine (CG), Prealbumin (PA)
Diagnostic antibodies and antigens for Companion Animal disease testing
● Rabbit
Diagnostic antibodies and antigens for Swine disease testing
Diagnostic antibodies and antigens for Avian disease testing
Diagnostic antibodies and antigens for Multiple animal disease testing
Diagnostic antibodies and antigens for Ruminant disease testing
● Deer
Diagnostic antibodies and antigens for infectious and non-infectious Equine/Horse disease testing
SOCAIL MEDIA
Liver is an important organ and it is responsible for the metabolism, energy storage, and waste filtering. Liver disease is a generally designates to any condition that affects the liver. These conditions may be because of different reasons, but all these reasons damage the liver and affect its function. Many people with liver disease do not cause any symptoms in the early stages. At a certain point in the development of liver disease damage can become irreversible and lead to liver failure, liver cancer, or death. Early diagnosis of liver disease may prevent liver damage. GENEMEDI produces core diagnostic ingredients such as collagen type IV, Procollagen III N-terminal peptide, Lithocholic Acid, deoxycholic acid, hyaluronic acid, Cholyglycine, Prealbumin and so on for test of Liver Diseases and related syndrome using ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT Kit.
Hyaluronic acid binding protein (HABP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
|---|---|---|---|---|---|---|---|---|
Human |
Hyaluronic acid binding protein |
GMP-h-HABP-Ag0101 |
Hyaluronic acid binding protein (HABP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HABP level test of Liver diseases (rheumatoid arthritis?(RA) andosteoarthritis) and related syndrome evaluation |
GMP-h-HABP-Ab01, GMP-h-HABP-Ab0201;GMP-h-HABP-Ab01, GMP-h-HABP-Ab0202:Anti-Human HABP mouse monoclonal antibody (mAb) |
Human Hyaluronic acid binding protein (HABP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Hyaluronic acid binding protein (HABP) antibodies in HABP level test of Liver diseases (rheumatoid arthritis?(RA) andosteoarthritis) and related syndrome evaluation. |
laminins (LN)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
|---|---|---|---|---|---|---|---|---|
Human |
laminins |
GMP-h-LN-Ag01 |
laminins (LN) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in LN level test of Liver diseases (muscular dystrophy, lethal
skin blistering disease (junctional epidermolysis bullosa) and nephrotic syndrome) and related syndrome evaluation |
GMP-h-LN-Ab01;GMP-h-LN-Ab02:Anti-Human LN mouse monoclonal antibody (mAb) |
Human laminins (LN) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other laminins (LN) antibodies in LN level test of Liver diseases (muscular dystrophy, lethal
skin blistering disease (junctional epidermolysis bullosa) and nephrotic syndrome) and related syndrome evaluation. |
collagen type IV (cIV)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
|---|---|---|---|---|---|---|---|---|
Human |
collagen type IV |
GMP-h-cIV-Ag01 |
collagen type IV (cIV) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in cIV level test of Liver diseases (Goodpasture syndrome, Alport syndrome,? glomerular basement membrane, Liver fibrosis and cirrhosis, alcoholic liver disease, hepatitis C and fall following successful therapy. autosomal dominant hereditary angiopathy, nephropathy, aneurysms, and muscle cramps.? porencephaly, schizencephaly, congenital cataract, coronary artery disease, diabetic nephropathy and renal injury.) and related syndrome evaluation |
GMP-h-cIV-Ab01;GMP-h-cIV-Ab02:Anti-Human cIV mouse monoclonal antibody (mAb) |
Human collagen type IV (cIV) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other collagen type IV (cIV) antibodies in cIV level test of Liver diseases (Goodpasture syndrome, Alport syndrome,? glomerular basement membrane, Liver fibrosis and cirrhosis, alcoholic liver disease, hepatitis C and fall following successful therapy. autosomal dominant hereditary angiopathy, nephropathy, aneurysms, and muscle cramps.? porencephaly, schizencephaly, congenital cataract, coronary artery disease, diabetic nephropathy and renal injury.) and related syndrome evaluation. |
Procollagen III N-terminal peptide (PIIINP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
|---|---|---|---|---|---|---|---|---|
Human |
Procollagen III N-terminal peptide |
GMP-h-PIIINP-Ag01 |
Procollagen III N-terminal peptide (PIIINP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in PIIINP level test of Liver diseases (liver fibrosis and cirrhosis) and related syndrome evaluation |
GMP-h-PIIINP-Ab01;GMP-h-PIIINP-Ab02:Anti-Human PIIINP mouse monoclonal antibody (mAb) |
Human Procollagen III N-terminal peptide (PIIINP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Procollagen III N-terminal peptide (PIIINP) antibodies in PIIINP level test of Liver diseases (liver fibrosis and cirrhosis) and related syndrome evaluation. |
Lithocholic Acid (LCA)
deoxycholic acid (cholanoic acid)
hyaluronic acid (HA)
Cholyglycine (CG)
Prealbumin (PA)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
|---|---|---|---|---|---|---|---|---|
Human |
Prealbumin |
GMP-h-PA-Ag01 |
Prealbumin (PA) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in PA level test of Liver diseases (liver disease, inflammation, or tissue death) and related syndrome evaluation |
GMP-h-PA-Ab01;GMP-h-PA-Ab02:Anti-Human PA mouse monoclonal antibody (mAb) |
Human Prealbumin (PA) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Prealbumin (PA) antibodies in PA level test of Liver diseases (liver disease, inflammation, or tissue death) and related syndrome evaluation. |
